Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
J. M. Cooper, J. A. Brown, R. Cairns & G. K. Isbister. (2017) Desvenlafaxine overdose and the occurrence of serotonin toxicity, seizures and cardiovascular effects. Clinical Toxicology 55:1, pages 18-24.
Read now
Read now
C. Reichert, P. Reichert, F. Monnet-Tschudi, H. Kupferschmidt, A. Ceschi & C. Rauber-Lüthy. (2014) Seizures after single-agent overdose with pharmaceutical drugs: Analysis of cases reported to a poison center. Clinical Toxicology 52:6, pages 629-634.
Read now
Read now
I. Berling & G. K. Isbister. (2014) Mirtazapine overdose is unlikely to cause major toxicity. Clinical Toxicology 52:1, pages 20-24.
Read now
Read now
Wendy Klein-Schwartz, Blaine E. Benson, Samantha C. Lee & Toby Litovitz. (2012) Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children. Clinical Toxicology 50:5, pages 418-423.
Read now
Read now
Angela Naderi-Heiden, Shahin Shadnia, Ali-Reza Salimi, Ahmad Naderi, Mohammad M. Naderi, Daniela Schmid, Andreas Gleiss, Siegfried Kasper & Richard Frey. (2009) Self-poisonings with tricyclic antidepressants and selective serotonin reuptake inhibitors in Tehran, Iran. The World Journal of Biological Psychiatry 10:4, pages 302-312.
Read now
Read now
Jonas Höjer, Johan Hulting & Heléne Salmonson. (2008) Fatal cardiotoxicity induced by venlafaxine overdosage. Clinical Toxicology 46:4, pages 336-337.
Read now
Read now
Lewis S. Nelson, Andrew R. Erdman, Lisa L. Booze, Daniel J. Cobaugh, Peter A. Chyka, Alan D. Woolf, Elizabeth J. Scharman, Paul M. Wax, Anthony S. Manoguerra, Gwenn Christianson, E. Martin Caravati & William G. Troutman. (2007) Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management. Clinical Toxicology 45:4, pages 315-332.
Read now
Read now
W. Stephen Waring, Alison M. Good & D. Nicholas Bateman. (2007) Lack of significant toxicity after mirtazapine overdose: A five-year review of cases admitted to a regional toxicology unit. Clinical Toxicology 45:1, pages 45-50.
Read now
Read now
Stefano Pallanti & Cláudio Sandner. (2007) Treatment of depression with selective serotonin inhibitors: the role of fluvoxamine. International Journal of Psychiatry in Clinical Practice 11:3, pages 233-238.
Read now
Read now
Lawrence N. Masullo, Michael A. Miller, S. David Baker, Sudip Bose & Marc Levsky. (2006) Clinical Course and Toxicokinetic Data Following Isolated Citalopram Overdose in an Infant. Clinical Toxicology 44:2, pages 165-168.
Read now
Read now
Miran Brvar, Martin Možina & Matjaž Bunc. (2005) Poisoning with Rivastigmine. Clinical Toxicology 43:7, pages 891-892.
Read now
Read now
Articles from other publishers (84)
Allison E. Jordan, Jason A. Webb, Nicole E. Bates, Chase B. Samsel, Manuel Trachsel, Jeremy M. Hirst & Scott A. Irwin. 2023. Evidence-Based Practice of Palliative Medicine. Evidence-Based Practice of Palliative Medicine
204
218
.
Craig M. Straley, Marisa Sochacki, Ellen Reed, Chelsea N. Carr & Terrence Bradley Baugh. (2022) Comparison of the effect of citalopram, bupropion, sertraline, and tricyclic antidepressants on QTc: A cross-sectional study. Journal of Affective Disorders 296, pages 476-484.
Crossref
Crossref
Margo Funk & Scott Beach. 2022. Torsades de Pointes. Torsades de Pointes
213
229
.
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry
305
450
.
Qiong Wang, Zhe Chen, Dingwen Chen, Shunbin Luo & Lingping Xie. (2020) Simultaneous quantification of vortioxetine, fluoxetine and their metabolites in rat plasma by UPLC–MS/MS. Biomedical Chromatography 34:12.
Crossref
Crossref
Wafa F S Badulla, Arın G Dal Poçan, Zeki Atkoşar & Göksel Arlı. (2020) Capillary Electrophoresis Method for Determination of Escitalopram Oxalate in Urine Samples and Different Dosage Forms. Journal of Chromatographic Science 58:8, pages 759-769.
Crossref
Crossref
Kerryanne Shearer, Julie McAdam & Michael Parsons. (2020) Drug levels in fatal cases where death was not directly attributable to drug toxicity. Forensic Toxicology 38:2, pages 536-541.
Crossref
Crossref
Sanja Vukadinović-Stojanović & Zlatan Stojanović. (2019) Analysis of effect of antidepressant drug venlafaxine on length of QT interval in patients with depressive disorder and alcohol dependence. Биомедицинска истраживања 10:1, pages 15-23.
Crossref
Crossref
Kane O. Pryor & Kingsley P. Storer. 2019. Pharmacology and Physiology for Anesthesia. Pharmacology and Physiology for Anesthesia
241
269
.
R. Bellmann & M. Joannidis. (2017) Vergiftungen mit psychotropen SubstanzenIntoxication with psychotropic drugs. Medizinische Klinik - Intensivmedizin und Notfallmedizin 112:6, pages 557-575.
Crossref
Crossref
Sofia Garcia, Michael Schuh, Anvir Cheema, Herjot Atwal & Paldeep S. Atwal. (2017) Palpitations and Asthenia Associated with Venlafaxine in a CYP2D6 Poor Metabolizer and CYP2C19 Intermediate Metabolizer. Case Reports in Genetics 2017, pages 1-4.
Crossref
Crossref
Bengt Danielsson, Julius Collin, Gudrun Jonasdottir Bergman, Natalia Borg, Peter Salmi & Johan Fastbom. (2016) Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study. British Journal of Clinical Pharmacology 81:4, pages 773-783.
Crossref
Crossref
James W. Dear & D Nicholas Bateman. (2016) Antidepressants. Medicine 44:3, pages 135-137.
Crossref
Crossref
Hamed Ghaedi, Abbas Afkhami, Tayyebeh Madrakian & Farzaneh Soltani-Felehgari. (2016) Construction of novel sensitive electrochemical sensor for electro-oxidation and determination of citalopram based on zinc oxide nanoparticles and multi-walled carbon nanotubes. Materials Science and Engineering: C 59, pages 847-854.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
1057
1062
.
Ben T. Tsutaoka, Raymond Y. Ho, Stacey M. Fung & Thomas E. Kearney. (2015) Comparative Toxicity of Tapentadol and Tramadol Utilizing Data Reported to the National Poison Data System. Annals of Pharmacotherapy 49:12, pages 1311-1316.
Crossref
Crossref
Suad A. Al-Abri, Claire Woodburn, Kent R. Olson & Thomas E. Kearney. (2015) Ventricular Dysrhythmias Associated with Poisoning and Drug Overdose: A 10-Year Review of Statewide Poison Control Center Data from California. American Journal of Cardiovascular Drugs 15:1, pages 43-50.
Crossref
Crossref
Rajesh R. Tampi, Michael Balderas, Kathleen V. Carter, Deena J. Tampi, Marian Moca, Amy Knudsen & Jacquelyn May. (2015) Citalopram, QTc Prolongation, and Torsades de Pointes. Psychosomatics 56:1, pages 36-43.
Crossref
Crossref
Natalia M. Jasiak & Jolene R. Bostwick. (2014) Risk of QT/QTc Prolongation Among Newer Non-SSRI Antidepressants. Annals of Pharmacotherapy 48:12, pages 1620-1628.
Crossref
Crossref
Yingying Kumar, Simon Kung & Gen Shinozaki. (2014) CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation. Journal of Psychopharmacology 28:12, pages 1143-1148.
Crossref
Crossref
Mehrul Hasnain & W. Victor R. Vieweg. (2014) QTc Interval Prolongation and Torsade de Pointes Associated with Second-Generation Antipsychotics and Antidepressants: A Comprehensive Review. CNS Drugs 28:10, pages 887-920.
Crossref
Crossref
Pablo Puras & Philip B. Mitchell. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
27
39
.
D Gunnell, K Hawton, O Bennewith, J Cooper, S Simkin, J Donovan, J Evans, D Longson, S O'Connor & N Kapur. (2013) A multicentre programme of clinical and public health research in support of the National Suicide Prevention Strategy for England. Programme Grants for Applied Research 1:1, pages 1-216.
Crossref
Crossref
David Taylor, Alan Lenox-Smith & Andrew Bradley. (2013) A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdose. Therapeutic Advances in Psychopharmacology 3:3, pages 151-161.
Crossref
Crossref
L. Karlsson, H. Green, A. L. Zackrisson, F. Bengtsson, I. Jakobsen Falk, B. Carlsson, J. Ahlner & F. C. Kugelberg. (2013) ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram. International Journal of Legal Medicine 127:3, pages 579-586.
Crossref
Crossref
J Jacob, D Albert & K Heard. (2012) Single-agent duloxetine ingestions. Human & Experimental Toxicology 32:4, pages 427-433.
Crossref
Crossref
M. J. Cooke & W. S. Waring. (2012) Citalopram and cardiac toxicity. European Journal of Clinical Pharmacology 69:4, pages 755-760.
Crossref
Crossref
Shane Darke, Michelle Torok & Johan Duflou. (2012) Contributory and Incidental Blood Concentrations in Deaths Involving Citalopram. Journal of Forensic Sciences 58:2, pages 432-435.
Crossref
Crossref
Scott R. Beach, Christopher M. Celano, Peter A. Noseworthy, James L. Januzzi & Jeff C. Huffman. (2013) QTc Prolongation, Torsades de Pointes, and Psychotropic Medications. Psychosomatics 54:1, pages 1-13.
Crossref
Crossref
Scott A. Irwin & Susan Block. 2013. Evidence-Based Practice in Palliative Medicine. Evidence-Based Practice in Palliative Medicine
181
190
.
Kane O. Pryor & Kingsley P. Storer. 2013. Pharmacology and Physiology for Anesthesia. Pharmacology and Physiology for Anesthesia
180
207
.
Borna Payandemehr, Arash Bahremand, Reza Rahimian, Pouya Ziai, Afsaneh Amouzegar, Mohammad Sharifzadeh & Ahmad Reza Dehpour. (2012) 5-HT3 receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: Involvement of nitric oxide. Epilepsy Research 101:3, pages 217-227.
Crossref
Crossref
D. Nicholas Bateman. (2012) Antidepressants. Medicine 40:2, pages 100-102.
Crossref
Crossref
Matthias Fischer, Stefan Unterecker & Bruno Pfuhlmann. (2012) Overdose of Venlafaxine with Mild Outcome. Neuroscience and Medicine 03:04, pages 327-329.
Crossref
Crossref
Maria Kingbäck, Louise Karlsson, Anna-Lena Zackrisson, Björn Carlsson, Martin Josefsson, Finn Bengtsson, Johan Ahlner & Fredrik C. Kugelberg. (2012) Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood. Forensic Science International 214:1-3, pages 124-134.
Crossref
Crossref
Terhi Launiainen, Ilpo Rasanen, Erkki Vuori & Ilkka Ojanperä. (2010) Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions. International Journal of Legal Medicine 125:3, pages 349-358.
Crossref
Crossref
Bezalel Dantz. (2011) Nefazodone Revisited. Psychiatric Annals 41:3, pages 184-191.
Crossref
Crossref
Lindsay Murray, Frank Daly, Mark Little & Mike Cadogan. 2011. Toxicology Handbook. Toxicology Handbook
127
370
.
David J NuttCelia L Feetam. (2010) What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology. Journal of Psychopharmacology 24:8, pages 1137-1141.
Crossref
Crossref
Bryan D. Hayes, Wendy Klein-Schwartz, Richard F. Clark, Allison A. Muller & Jane E. Miloradovich. (2010) Comparison of Toxicity of Acute Overdoses with Citalopram and Escitalopram. The Journal of Emergency Medicine 39:1, pages 44-48.
Crossref
Crossref
Agnes N. Chan, Naren Gunja & Christopher J. Ryan. (2010) A Comparison of Venlafaxine and SSRIs in Deliberate Self-poisoning. Journal of Medical Toxicology 6:2, pages 116-121.
Crossref
Crossref
K. Hawton, H. Bergen, S. Simkin, J. Cooper, K. Waters, D. Gunnell & N. Kapur. (2010) Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. The British Journal of Psychiatry 196:5, pages 354-358.
Crossref
Crossref
Julien Déglon, Estelle Lauer, Aurélien Thomas, Patrice Mangin & Christian Staub. (2010) Use of the dried blood spot sampling process coupled with fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry: application to fluoxetine, norfluoxetine, reboxetine, and paroxetine analysis. Analytical and Bioanalytical Chemistry 396:7, pages 2523-2532.
Crossref
Crossref
Frank Barile. 2010. Clinical Toxicology. Clinical Toxicology
203
218
.
Peter M. Haddad. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
29
40
.
Sarah M. R. Wille, Els A. De Letter, Michel H. A. Piette, Lien K. Van Overschelde, Carlos H. Van Peteghem & Willy E. Lambert. (2008) Determination of antidepressants in human postmortem blood, brain tissue, and hair using gas chromatography–mass spectrometry. International Journal of Legal Medicine 123:6, pages 451-458.
Crossref
Crossref
David Taylor, Carol Paton & Shitij Kapur. 2009. The Maudsley Prescribing Guidelines, Tenth Edition. The Maudsley Prescribing Guidelines, Tenth Edition
155
250
.
Klaus Romero & Raymond L. Woosley. (2009) Clarification to the www.qtdrugs.org updated lists. Pharmacoepidemiology and Drug Safety 18:5, pages 423-424.
Crossref
Crossref
Brandon Wills, Brett J. Theeler & John P. Ney. 2009. Clinical Neurotoxicology. Clinical Neurotoxicology
131
150
.
W. Stephen Waring, Julie A. Gray & Ann Graham. (2008) Predictive factors for generalized seizures after deliberate citalopram overdose. British Journal of Clinical Pharmacology 66:6, pages 861-865.
Crossref
Crossref
Afra Jimmink, Klaartje Caminada, Nicole G M Hunfeld & Daan J Touw. (2008) Clinical Toxicology of Citalopram After Acute Intoxication With the Sole Drug or in Combination With Other Drugs: Overview of 26 Cases. Therapeutic Drug Monitoring 30:3, pages 365-371.
Crossref
Crossref
Asim F. Tarabar, Robert S. Hoffman & Lewis S. Nelson. (2008) Citalopram overdose: Late presentation of torsades de pointes (TdP) with cardiac arrest. Journal of Medical Toxicology 4:2, pages 101-105.
Crossref
Crossref
Habib Bagheri, Faezeh Khalilian, Esmaeil Babanezhad, Ali Es-haghi & Mohammad-Reza Rouini. (2008) Modified solvent microextraction with back extraction combined with liquid chromatography-fluorescence detection for the determination of citalopram in human plasma. Analytica Chimica Acta 610:2, pages 211-216.
Crossref
Crossref
Gustav Drasch, Felicitas Dahlmann, Ludwig von Meyer, Gabriele Roider & Wolfgang Eisenmenger. (2007) Frequency of different anti-depressants associated with suicides and drug deaths. International Journal of Legal Medicine 122:2, pages 115-121.
Crossref
Crossref
David G.S. Perahia, Yili Lu Pritchett, Daniel K. Kajdasz, Michael Bauer, Rakesh Jain, James M. Russell, Daniel J. Walker, Kimberly A. Spencer, Debbie M. Froud, Joel Raskin & Michael E. Thase. (2008) A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. Journal of Psychiatric Research 42:1, pages 22-34.
Crossref
Crossref
Kenneth Alper. 2008. Psychiatric Controversies in Epilepsy. Psychiatric Controversies in Epilepsy
255
267
.
Robert J. Flanagan. (2008) Fatal toxicity of drugs used in psychiatry. Human Psychopharmacology: Clinical and Experimental 23:S1, pages S43-S51.
Crossref
Crossref
Mei Cheng, Hai-qing Gao, Ling Xu, Bao-ying Li, Hong Zhang & Xian-hua Li. (2007) Cardioprotective Effects of Grape Seed Proanthocyanidins Extracts in Streptozocin Induced Diabetic Rats. Journal of Cardiovascular Pharmacology 50:5, pages 503-509.
Crossref
Crossref
D. Nicholas Bateman. (2007) Antidepressants. Medicine 35:11, pages 587-589.
Crossref
Crossref
C. Howell, A. D. Wilson & W. S. Waring. (2007) Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases. British Journal of Clinical Pharmacology 64:2, pages 192-197.
Crossref
Crossref
Kenneth Alper, Kelly A. Schwartz, Russell L. Kolts & Arif Khan. (2007) Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports. Biological Psychiatry 62:4, pages 345-354.
Crossref
Crossref
Tracey H. Reilly & Mark A. Kirk. (2007) Atypical Antipsychotics and Newer Antidepressants. Emergency Medicine Clinics of North America 25:2, pages 477-497.
Crossref
Crossref
Nina Johannesson & Jonas Bergquist. (2007) Rapid on-line extraction and quantification of escitalopram from urine using sol–gel columns and mass spectrometric detection. Journal of Pharmaceutical and Biomedical Analysis 43:3, pages 1045-1048.
Crossref
Crossref
Paul McNally, Fiona McNicholas & Paul Oslizlok. (2006) The QT interval and psychotropic medications in children. European Child & Adolescent Psychiatry 16:1, pages 33-47.
Crossref
Crossref
A.D. WILSON, C. HOWELL & W.S. WARING. (2007) VENLAFAXINE INGESTION IS ASSOCIATED WITH RHABDOMYOLYSIS IN ADULTS: A CASE SERIES. The Journal of Toxicological Sciences 32:1, pages 97-101.
Crossref
Crossref
JEFFREY BRENT & ROBERT PALMER. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose
561
577
.
DN Bateman, HKR Thanacoody & WS Waring. (2006) Digitalis intoxication induced by paroxetine co-administration. The Lancet 368:9551, pages 1962-1963.
Crossref
Crossref
Joseph J. Rasimas & Keith K. Burkhart. (2006) Cardiac conduction disturbances after an overdose of nefazodone and gabapentin. The American Journal of Emergency Medicine 24:7, pages 886-888.
Crossref
Crossref
P Unverir, R Atilla, O Karcioglu, H Topacoglu, Y Demiral & Y Tuncok. (2016) A retrospective analysis of antidepressant poisonings in the emergency department: 11-year experience. Human & Experimental Toxicology 25:10, pages 605-612.
Crossref
Crossref
David Taylor & J Railton Scott. (2006) Volte-faceon venlafaxine – reasons and reflections. Journal of Psychopharmacology 20:5, pages 597-601.
Crossref
Crossref
Sean Ekins, Konstantin V. Balakin, Nikolay Savchuk & Yan Ivanenkov. (2006) Insights for Human Ether-a-Go-Go-Related Gene Potassium Channel Inhibition Using Recursive Partitioning and Kohonen and Sammon Mapping Techniques. Journal of Medicinal Chemistry 49:17, pages 5059-5071.
Crossref
Crossref
Wei Ni & Stephanie W Watts. (2006) 5-HYDROXYTRYPTAMINE IN THE CARDIOVASCULAR SYSTEM: FOCUS ON THE SEROTONIN TRANSPORTER (SERT). Clinical and Experimental Pharmacology and Physiology 33:7, pages 575-583.
Crossref
Crossref
H. G. M. Westenberg & C. Sandner. (2006) Tolerability and safety of fluvoxamine and other antidepressants. International Journal of Clinical Practice 60:4, pages 482-491.
Crossref
Crossref
Brandon Wills & Timothy Erickson. (2006) Chemically Induced Seizures. Clinics in Laboratory Medicine 26:1, pages 185-209.
Crossref
Crossref
P Ken Gillman. (2006) A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status. Human Psychopharmacology: Clinical and Experimental 21:2, pages 117-125.
Crossref
Crossref
Frank LoVecchio, David Watts, Joseph Winchell, Jason Knight & Tim McDowell. (2006) Outcomes after supratherapeutic escitalopram ingestions. The Journal of Emergency Medicine 30:1, pages 17-19.
Crossref
Crossref
S. A. Montgomery. (2005) Antidepressants and seizures: emphasis on newer agents and clinical implications. International Journal of Clinical Practice 59:12, pages 1435-1440.
Crossref
Crossref
Sarah M.R. Wille, Kristof E. Maudens, Carlos H. Van Peteghem & Willy E.E. Lambert. (2005) Development of a solid phase extraction for 13 ‘new’ generation antidepressants and their active metabolites for gas chromatographic–mass spectrometric analysis. Journal of Chromatography A 1098:1-2, pages 19-29.
Crossref
Crossref
Brandon Wills & Timothy Erickson. (2005) Drug- and Toxin-Associated Seizures. Medical Clinics of North America 89:6, pages 1297-1321.
Crossref
Crossref
Anna Koski, Erkki Vuori & Ilkka Ojanperä. (2005) Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data. International Journal of Legal Medicine 119:6, pages 344-348.
Crossref
Crossref
Edward Mills, Ping Wu, Bradley C Johnston, Keith Gallicano, Mike Clarke & Gordon Guyatt. (2005) Natural Health Product-Drug Interactions. Therapeutic Drug Monitoring 27:5, pages 549-557.
Crossref
Crossref
Stephen M. Stahl, Meghan M. Grady, Chantal Moret & Mike Briley. (2014) SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants. CNS Spectrums 10:9, pages 732-747.
Crossref
Crossref
Margareta Reis, Jiri Prochazka, Ad Sitsen, Johan Ahlner & Finn Bengtsson. (2005) Inter- and Intraindividual Pharmacokinetic Variations of Mirtazapine and Its N-Demethyl Metabolite in Patients Treated for Major Depressive Disorder. Therapeutic Drug Monitoring 27:4, pages 469-477.
Crossref
Crossref
D. N. Bateman, J. Chick, A. M. Good, C. A. Kelly & G. Masterton. (2004) Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?. European Journal of Clinical Pharmacology 60:3, pages 221-224.
Crossref
Crossref